Variant report
Variant | esv1823979 |
---|---|
Chromosome Location | chr19:56264673-56307596 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:147)
- CpG islands (count:305)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:56269259-56269309 | AG09309 | skin: | n/a |
2 | chr19:56270498-56270548 | PANC-1 | pancreas: | n/a |
3 | chr19:56274428-56274478 | HCT-116 | colon: | n/a |
4 | chr19:56269246-56269296 | HRE | kidney: | n/a |
5 | chr19:56269246-56269296 | HNPCEpiC | eye: | n/a |
6 | chr19:56270498-56270548 | HRPEpiC | eye: | n/a |
7 | chr19:56269259-56269309 | PFSK-1 | brain: | n/a |
8 | chr19:56270498-56270548 | MCF10A-Er-Src | breast: | n/a |
9 | chr19:56274428-56274478 | HMEC | breast: | n/a |
10 | chr19:56270729-56270779 | AG09319 | gingival: | n/a |
11 | chr19:56270498-56270548 | GM12891 | blood: | n/a |
12 | chr19:56274428-56274478 | GM12891 | blood: | n/a |
13 | chr19:56269259-56269309 | H1-hESC | embryonic stem cell: | embryo |
14 | chr19:56270729-56270779 | Caco-2 | colon: | n/a |
15 | chr19:56270729-56270779 | AG09309 | skin: | n/a |
16 | chr19:56270498-56270548 | IMR90 | lung: | fetal |
17 | chr19:56269246-56269296 | HPAEpiC | pulmonary alveolar: | n/a |
18 | chr19:56269259-56269309 | K562 | blood: | n/a |
19 | chr19:56269259-56269309 | IMR90 | lung: | fetal |
20 | chr19:56269259-56269309 | HPAEpiC | pulmonary alveolar: | n/a |
21 | chr19:56269259-56269309 | GM12891 | blood: | n/a |
22 | chr19:56270729-56270779 | HPAEpiC | pulmonary alveolar: | n/a |
23 | chr19:56274428-56274478 | HCM | heart: | n/a |
24 | chr19:56269259-56269309 | NT2-D1 | testis: | n/a |
25 | chr19:56270498-56270548 | HAEpiC | amniotic membrane: | n/a |
26 | chr19:56269259-56269309 | SAEC | small airway: | n/a |
27 | chr19:56274428-56274478 | K562 | blood: | n/a |
28 | chr19:56270729-56270779 | A549 | lung: | n/a |
29 | chr19:56274428-56274478 | GM06990 | blood: | n/a |
30 | chr19:56270498-56270548 | Jurkat | blood: | n/a |
31 | chr19:56270498-56270548 | HMEC | breast: | n/a |
32 | chr19:56270729-56270779 | HUVEC | blood vessel: | n/a |
33 | chr19:56274428-56274478 | HepG2 | liver: | n/a |
34 | chr19:56269259-56269309 | SK-N-SH_RA | brain: | n/a |
35 | chr19:56270729-56270779 | NH-A | brain: | n/a |
36 | chr19:56270498-56270548 | AoSMC | blood vessel: | n/a |
37 | chr19:56270498-56270548 | AG04450 | lung: | fetal |
38 | chr19:56274428-56274478 | NT2-D1 | testis: | n/a |
39 | chr19:56269246-56269296 | PANC-1 | pancreas: | n/a |
40 | chr19:56269246-56269296 | ProgFib | skin: | n/a |
41 | chr19:56270729-56270779 | Jurkat | blood: | n/a |
42 | chr19:56270729-56270779 | AG10803 | skin: | n/a |
43 | chr19:56269246-56269296 | MCF-7 | breast: | n/a |
44 | chr19:56269259-56269309 | CMK | blood: | n/a |
45 | chr19:56274428-56274478 | HRE | kidney: | n/a |
46 | chr19:56270729-56270779 | SK-N-MC | brain: | n/a |
47 | chr19:56270729-56270779 | HEK293 | kidney: | embryo |
48 | chr19:56270498-56270548 | SKMC | muscle: | n/a |
49 | chr19:56274428-56274478 | U87 | brain: | n/a |
50 | chr19:56270729-56270779 | HL-60 | blood: | n/a |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:56271991..56273573-chr19:56281048..56283702,2 | K562 | blood: | |
2 | chr19:56271991..56273573-chr19:56281048..56283702,2 | K562 | blood: | |
3 | chr19:56294175..56296046-chr19:56307232..56309273,2 | MCF-7 | breast: | |
4 | chr17:41464575..41466240-chr19:56288867..56290367,2 | K562 | blood: | |
5 | chr19:56288962..56289563-chr19:56320651..56321410,3 | MCF-7 | breast: | |
6 | chr19:56294175..56296046-chr19:56307232..56309273,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RFPL4AL1 | TF binding region |
RFPL4AP1 | TF binding region |
RFPL4A | TF binding region |
RFPL4AL1 | CpG island |
RFPL4AP1 | CpG island |
RFPL4A | CpG island |
ENSG00000188825 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184924614 | chr19:56264695-56264696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529138402 | chr19:56264697-56264698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs538627791 | chr19:56264716-56264717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs377731929 | chr19:56264744-56264745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs74419760 | chr19:56264811-56264812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs34837325 | chr19:56264818-56264819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs386389299 | chr19:56264833-56264834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376868498 | chr19:56264834-56264835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546125296 | chr19:56264836-56264837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369229271 | chr19:56264837-56264838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs57710529 | chr19:56264849-56264850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs74179636 | chr19:56264850-56264851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs143044120 | chr19:56264869-56264870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs73933326 | chr19:56264884-56264885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs144677097 | chr19:56264977-56264978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs115133371 | chr19:56264983-56264984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111482761 | chr19:56265013-56265014 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs189778113 | chr19:56265074-56265075 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs34047470 | chr19:56265091-56265092 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs537119347 | chr19:56265096-56265097 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs556806436 | chr19:56265120-56265121 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs73055904 | chr19:56265121-56265122 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536488226 | chr19:56265132-56265133 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs371149632 | chr19:56265144-56265145 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553248027 | chr19:56265165-56265166 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376628600 | chr19:56265169-56265170 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs12460887 | chr19:56265195-56265196 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533568271 | chr19:56265203-56265204 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs182434812 | chr19:56265204-56265205 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148496136 | chr19:56265205-56265206 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554064513 | chr19:56265206-56265207 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558884325 | chr19:56265217-56265218 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575578302 | chr19:56265277-56265278 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142876336 | chr19:56265373-56265374 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561267633 | chr19:56265391-56265392 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs529100428 | chr19:56265393-56265394 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs187110494 | chr19:56265420-56265421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559594582 | chr19:56265426-56265427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs57963573 | chr19:56265476-56265477 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs35370140 | chr19:56265502-56265503 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs571199256 | chr19:56265534-56265535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs572910825 | chr19:56265557-56265558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs370330819 | chr19:56265580-56265581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs540345493 | chr19:56265597-56265598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs17634917 | chr19:56265664-56265665 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | disease |
46 | rs567069693 | chr19:56265684-56265685 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs535945096 | chr19:56265696-56265697 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs553117017 | chr19:56265709-56265710 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs80063101 | chr19:56265714-56265715 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538925233 | chr19:56265754-56265755 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 20459607 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Heart disease | 21282601 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21509527 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 20409316 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:56264400-56265000 | Enhancers | Liver | Liver |
2 | chr19:56264800-56265600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
3 | chr19:56265000-56265400 | Flanking Active TSS | Liver | Liver |
4 | chr19:56265000-56266000 | Enhancers | Pancreas | Pancrea |
5 | chr19:56265400-56265600 | Enhancers | Liver | Liver |
6 | chr19:56265400-56265800 | Enhancers | Gastric | stomach |
7 | chr19:56265600-56265800 | Flanking Active TSS | Liver | Liver |
8 | chr19:56265800-56268200 | Weak transcription | Liver | Liver |
9 | chr19:56266000-56266800 | Weak transcription | Pancreas | Pancrea |
10 | chr19:56266800-56267000 | Enhancers | Pancreas | Pancrea |
11 | chr19:56267000-56268200 | Weak transcription | Pancreas | Pancrea |
12 | chr19:56268000-56269800 | Enhancers | Primary monocytes fromperipheralblood | blood |
13 | chr19:56268200-56268400 | ZNF genes & repeats | Liver | Liver |
14 | chr19:56268200-56268400 | Enhancers | Pancreas | Pancrea |
15 | chr19:56268400-56272600 | Weak transcription | Liver | Liver |
16 | chr19:56269800-56270200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
17 | chr19:56270200-56271800 | Enhancers | Primary monocytes fromperipheralblood | blood |
18 | chr19:56272600-56272800 | Active TSS | Liver | Liver |
19 | chr19:56277000-56279600 | Enhancers | Primary monocytes fromperipheralblood | blood |
20 | chr19:56278000-56278200 | Bivalent Enhancer | Primary hematopoietic stem cells short term culture | blood |
21 | chr19:56279600-56280000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
22 | chr19:56280000-56281800 | Enhancers | Primary monocytes fromperipheralblood | blood |
23 | chr19:56281200-56281800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
24 | chr19:56293200-56293400 | Enhancers | Hela-S3 | cervix |
25 | chr19:56295400-56295600 | ZNF genes & repeats | iPS-15b Cell Line | embryonic stem cell |
26 | chr19:56300600-56304000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
27 | chr19:56306200-56310800 | Weak transcription | Pancreas | Pancrea |
28 | chr19:56307400-56313400 | Weak transcription | Liver | Liver |